Average Co-Inventor Count = 4.12
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (29 from 3,684 patents)
2. Bristol-myers Company (2 from 637 patents)
3. Institute of Organic Chemistry and Biochemistry of the Academy of (2 from 22 patents)
4. Rega Stichting, V.z.w. (2 from 21 patents)
5. Bristol-myers Squibb (1 from 36 patents)
34 patents:
1. 10174024 - 5H-pyrido[3,2-B]indole compounds as anticancer agents
2. 9751879 - Tricyclic compounds as anticancer agents
3. 9725449 - Tricyclic compounds as anticancer agents
4. 8350084 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
5. 8093276 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
6. 8084477 - Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
7. 8044077 - Alpha-(N-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
8. 7169803 - N-substituted prodrugs of fluorooxindoles
9. 7151180 - Potassium channel modulators
10. 7091202 - 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators
11. 6930100 - Phosphate prodrugs of fluoroxindoles
12. 6613786 - Thiophenyl triazol-3-one derivatives as smooth muscle relaxants
13. 6297241 - Carbamate derivatives of diaryl 1,3,4-oxadiazolone
14. 6271249 - Diphenyl imidazoles as potassium channel modulators
15. 6184231 - 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators